BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36967783)

  • 1. Comprehensive analysis of the biological functions of endoplasmic reticulum stress in prostate cancer.
    Cen S; Jiang D; Lv D; Xu R; Hou J; Yang Z; Wu P; Xiong X; Gao X
    Front Endocrinol (Lausanne); 2023; 14():1090277. PubMed ID: 36967783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma.
    Li L; Yang Z; Zheng Y; Chen Z; Yue X; Bian E; Zhao B
    BMC Neurol; 2022 May; 22(1):192. PubMed ID: 35614390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of an endoplasmic reticulum stress-related signature in lung adenocarcinoma by comprehensive bioinformatics analysis.
    Wang Y; Nie J; Dai L; Hu W; Han S; Zhang J; Chen X; Ma X; Tian G; Wu D; Zhang Z; Long J; Fang J
    BMC Pulm Med; 2023 May; 23(1):172. PubMed ID: 37189138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis.
    Lin Y; Li T; Li Z; Shen C; Wu Z; Zhang Z; Li Z; Yang S; Wang Z; Li P; Fu C; Guo J; Hu H
    Front Genet; 2023; 14():1097179. PubMed ID: 37091788
    [No Abstract]   [Full Text] [Related]  

  • 6. Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma.
    Xu Z; Chen S; Zhang Y; Liu R; Chen M
    Front Immunol; 2022; 13():869759. PubMed ID: 35603206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment.
    Hu B; Zhang X; Zhu S; Wang C; Deng Z; Wang T; Wu Y
    Eur J Med Res; 2024 Jan; 29(1):92. PubMed ID: 38297388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of novel inflammatory response-related gene signature to predict prostate cancer recurrence and response to immune checkpoint therapy.
    Luo Y; Liu X; Lin J; Zhong W; Chen Q
    Math Biosci Eng; 2022 Aug; 19(11):11345-11366. PubMed ID: 36124593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An endoplasmic reticulum stress-related signature featuring ASNS for predicting prognosis and immune landscape in prostate cancer.
    Wu Z; Wu Z; Zeng J; Liu Y; Wang Y; Li H; Xia T; Liu W; Lin Z; Xu W
    Aging (Albany NY); 2024 Jan; 16(1):43-65. PubMed ID: 38206293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuproptosis illustrates tumor micro-environment features and predicts prostate cancer therapeutic sensitivity and prognosis.
    Cheng B; Tang C; Xie J; Zhou Q; Luo T; Wang Q; Huang H
    Life Sci; 2023 Jul; 325():121659. PubMed ID: 37011878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer.
    Hu D; Cao Q; Tong M; Ji C; Li Z; Huang W; Jin Y; Tong G; Wang Y; Li P; Zhang H
    BMC Med Genomics; 2022 Feb; 15(1):24. PubMed ID: 35135561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer.
    Cai J; Ji Z; Wu J; Chen L; Zheng D; Chen Y; Zhang X; Xie W; Huang J; Chen M; Lin R; Lin W; Chen Y; Li Z
    Front Genet; 2022; 13():949314. PubMed ID: 36092873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer.
    Ren L; Yang X; Wang W; Lin H; Huang G; Liu Z; Pan J; Mao X
    Front Genet; 2023; 14():1096783. PubMed ID: 36911392
    [No Abstract]   [Full Text] [Related]  

  • 14. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
    Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
    J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
    [No Abstract]   [Full Text] [Related]  

  • 15. The endoplasmic reticulum stress-related genes and molecular typing predicts prognosis and reveals characterization of tumor immune microenvironment in lung squamous cell carcinoma.
    Wang R; Huang Y; He J; Jin S; Li X; Tan K; Xia W
    Discov Oncol; 2024 Feb; 15(1):37. PubMed ID: 38363409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Breast Cancer Subtypes Based on Endoplasmic Reticulum Stress-Related Genes and Analysis of Prognosis and Immune Microenvironment in Breast Cancer Patients.
    Yi C; Yang J; Zhang T; Qin L; Chen D
    Technol Cancer Res Treat; 2024; 23():15330338241241484. PubMed ID: 38725284
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioinformatics analysis of the endoplasmic reticulum stress-related prognostic model and immune cell infiltration in acute myeloid leukemia.
    Pan M; Zhou J; Jiao C; Ge J
    Hematology; 2023 Dec; 28(1):2221101. PubMed ID: 37294065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of endoplasmic reticulum stress-related lncRNAs in lung adenocarcinoma by bioinformatics and experimental validation.
    Xin T; Sun Y; Meng H; Zhang N; Peng B; Yang X; Hu J; Cao M
    Ann Med; 2023; 55(2):2251500. PubMed ID: 37643369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Risk Signature and Comprehensive Analyses of Endoplasmic Reticulum Stress-Related Genes in Lung Adenocarcinoma.
    Yang C; Wei Y; Li W; Wei J; Chen G; Xu M; Liu G
    J Immunol Res; 2022; 2022():6567916. PubMed ID: 35571564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer.
    Han C; Deng Y; Yang B; Hu P; Hu B; Wang T; Liu J; Xia Q; Liu X
    Front Immunol; 2023; 14():1126902. PubMed ID: 36891298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.